Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Multi Indocitra Tbk. (MICE) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Multi Indocitra Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Multi Indocitra Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Indocitra Tbk. trades at Rp540 (market cap 336B, 8.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Multi Indocitra Tbk. is far larger — about 2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 8.4K). Which is the better fit depends on your goals.

MICEOBAT
Market Cap
336B166.01B
Volume
8.4K324K
Lot
843.24K
Turnover
4.58M77.68M
Average Price
545.54239.75
Value
4.58M77.68M
Indicative Equilibrium Price
240
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MICE
View details
OBAT
View details

About Multi Indocitra Tbk.

PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.

Read more on MICE

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT